Interim analyses and stopping rules in cancer clinical trials
- 1 December 1993
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 68 (6) , 1179-1185
- https://doi.org/10.1038/bjc.1993.500
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- When to stop a clinical trial.BMJ, 1992
- Overrunning and underrunning in sequential clinical trialsControlled Clinical Trials, 1992
- Corticosteroids Prevent Early Deterioration in Patients with Moderately Severe Pneumocystis carinii Pneumonia and the Acquired Immunodeficiency Syndrome (AIDS)Annals of Internal Medicine, 1990
- The impact that group sequential tests would have made on ECOG clinical trials. Gary Rosner and Anastasios A. Tsiatis, Statistics in Medicine, 8, 505–516 (1989)Statistics in Medicine, 1990
- Comparison of Bayesian with group sequential methods for monitoring clinical trialsControlled Clinical Trials, 1989
- The impact that group sequential tests would have made on ECOG clinical trialsStatistics in Medicine, 1989
- Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for LeukemiaNew England Journal of Medicine, 1986
- The analysis of a sequential clinical trial for the comparison of two lung cancer treatmentsStatistics in Medicine, 1983
- The design of a sequential clinical trial for the comparison of two lung cancer treatmentsStatistics in Medicine, 1982
- Calcium Chloride and Adrenaline as Bronchial Dilators Compared by Sequential AnalysisBMJ, 1954